Sharkey, Howes & Javer Bristol Myers Squibb CO Transaction History

Sharkey, Howes & Javer

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$42.77 - $50.71 $124,033 - $147,059	-2,900 Closed	0 $0
Q2 2018 Jul 26, 2018	SELL	$50.53 - $62.98 $65,689 - $81,874	-1,300 Reduced 30.95%	2,900 $160,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $77,922 - $84,954	1,300 Added 44.83%	4,200 $257,000
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $160,167 - $184,846	2,900	2,900 $189,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sharkey, Howes & Javer, based on Form 13F filings with the SEC.

Stay updated on Sharkey, Howes & Javer with notifications on news.